Efron Paul
SEC insider (Form 3/4/5 filer). CIK 0002024711. Director at Keenova Therapeutics plc (NONE). 7 reported Form 4/5 transactions since Sep 2024; latest on Jul 15, 2026. Located in BRIDGEWATER, NJ.
Companies Efron Paul has filed insider reports for
- Keenova Therapeutics plc (NONE): Director
Efron Paul
CIK: 0002024711
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Keenova Therapeutics plc
Discretionary Trading P&L
Holdings
Transaction History (7 total)
- Jul 15, 2026No ticker
Keenova Therapeutics plc
AwardDirectRestricted Stock Units
4.4K shares- - Jun 2, 2026No ticker
Keenova Therapeutics plc
DispositionDirectRestricted Stock Units
2.9K shares- - Jun 2, 2026No ticker
Keenova Therapeutics plc
Tax PaymentDirect825 shares- - Jun 2, 2026No ticker
Keenova Therapeutics plc
ExerciseDirect3.6K shares- - Feb 23, 2026No ticker
Keenova Therapeutics plc
AwardDirectRestricted Stock Units
4K shares- - Aug 18, 2025No ticker
Mallinckrodt plc
AwardDirect7.7K shares at avg. $92.30$710K - Aug 14, 2025No ticker
Mallinckrodt plc
AwardDirectRestricted Stock Units
5.4K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jul 15, 2026 | No ticker Keenova Therapeutics plc | Award Restricted Stock Units | 4,406 | - | - | Direct |
| Jun 2, 2026 | No ticker Keenova Therapeutics plc | Disposition Restricted Stock Units | 2,930 | - | - | Direct |
| Jun 2, 2026 | No ticker Keenova Therapeutics plc | Tax Payment | 825 | - | $0 | Direct |
| Jun 2, 2026 | No ticker Keenova Therapeutics plc | Exercise | 3,580 | - | $0 | Direct |
| Feb 23, 2026 | No ticker Keenova Therapeutics plc | Award Restricted Stock Units | 3,984 | - | - | Direct |
| Aug 18, 2025 | No ticker Mallinckrodt plc | Award | 7,692 | $92.30 | $709,972 | Direct |
| Aug 14, 2025 | No ticker Mallinckrodt plc | Award Restricted Stock Units | 5,417 | - | - | Direct |
1-7 of 7 transactions